Infinitus vs Waystar

Waystar is a public company, listed on Nasdaq as WAY since its June 2024 IPO, and it closed its acquisition of Iodine Software around October 1, 2025. Its homepage covers eligibility, authorizations, claim and payer payment management, remittance, denials and patient payments, and Waystar says it reaches 60% of the U.S. patient population and 1M+ providers. Infinitus's agents call payers to collect benefits and authorization status, and neither homepage names an EHR. A hospital authorization team that spends its day on hold with payers buys Infinitus. A health system finance office that wants a vendor filing 10-Ks buys Waystar. For a revenue cycle lead who needs claims, remittance and patient payments under the same contract as authorizations, Infinitus loses. Waystar shows HITRUST, SOC 2, PCI and HIPAA badges with no scope given, and Infinitus says it performs SOC 2 Type II auditing, with the report available through sales.